These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20158950)

  • 1. A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis).
    Shipley ST; Panda A; Khan AQ; Kriel EH; Maciel M; Livio S; Nataro JP; Levine MM; Sztein MB; DeTolla LJ
    Comp Med; 2010 Feb; 60(1):54-61. PubMed ID: 20158950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an intragastric challenge model for Shigella dysenteriae 1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment of Shigella vaccine formulations.
    Islam D; Ruamsap N; Khantapura P; Aksomboon A; Srijan A; Wongstitwilairoong B; Bodhidatta L; Gettayacamin M; Venkatesan MM; Mason CJ
    APMIS; 2014 Jun; 122(6):463-75. PubMed ID: 24028276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential response of the cynomolgus macaque gut microbiota to Shigella infection.
    Seekatz AM; Panda A; Rasko DA; Toapanta FR; Eloe-Fadrosh EA; Khan AQ; Liu Z; Shipley ST; Detolla LJ; Sztein MB; Fraser CM
    PLoS One; 2013; 8(6):e64212. PubMed ID: 23755118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trial.
    Launay O; Sadorge C; Jolly N; Poirier B; Béchet S; van der Vliet D; Seffer V; Fenner N; Dowling K; Giemza R; Johnson J; Ndiaye A; Vray M; Sansonetti P; Morand P; Poyart C; Lewis D; Gougeon ML
    Vaccine; 2009 Feb; 27(8):1184-91. PubMed ID: 19135496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential host immune responses to epidemic and endemic strains of Shigella dysenteriae type I.
    Sayem MA; Ahmad SM; Rekha RS; Sarker P; Agerberth B; Talukder KA; Raqib R
    J Health Popul Nutr; 2011 Oct; 29(5):429-37. PubMed ID: 22106748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide-specific antibodies in plasma and stools of children with Shigella-associated leukemoid reaction and hemolytic-uremic syndrome.
    Azim T; Qadri F; Ahmed S; Sarker MS; Halder RC; Hamadani J; Chowdhury A; Wahed MA; Salam MA; Albert MJ
    Clin Diagn Lab Immunol; 1996 Nov; 3(6):701-5. PubMed ID: 8914761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine.
    Venkatesan MM; Hartman AB; Newland JW; Ivanova VS; Hale TL; McDonough M; Butterton J
    Infect Immun; 2002 Jun; 70(6):2950-8. PubMed ID: 12010984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rhesus macaque intragastric challenge model for evaluating the safety, immunogenicity, and efficacy of live-attenuated
    Ruamsap N; Imerbsin R; Khanijou P; Gonwong S; Oransathit W; Barnoy S; Venkatesan MM; Chaudhury S; Islam D
    Front Microbiol; 2024; 15():1454338. PubMed ID: 39309527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate.
    McKenzie R; Venkatesan MM; Wolf MK; Islam D; Grahek S; Jones AM; Bloom A; Taylor DN; Hale TL; Bourgeois AL
    Vaccine; 2008 Jun; 26(26):3291-6. PubMed ID: 18468742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live non-invasive Shigella dysenteriae 1 strain induces homologous protective immunity in a guinea pig colitis model.
    Barman S; Kumar R; Chowdhury G; Rani Saha D; Wajima T; Hamabata T; Ramamurthy T; Balakrish Nair G; Takeda Y; Koley H
    Microbiol Immunol; 2011 Oct; 55(10):683-93. PubMed ID: 21806676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An environmental Escherichia albertii strain, DM104, induces protective immunity to Shigella dysenteriae in guinea pig eye model.
    Chowdhury FM; Rahman MZ; Khan SI; Ahsan CR; Birkeland NK
    Curr Microbiol; 2014 May; 68(5):642-7. PubMed ID: 24452425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against shigellosis caused by Shigella dysenteriae serotype 4 in guinea pigs using Escherichia albertii DM104 as a live vaccine candidate strain.
    Chowdhury FM; Rahman MZ; Sarkar MMH; Rabbi F; Khan SI; Ahsan CR; Birkeland NK
    Acta Microbiol Immunol Hung; 2017 Jun; 64(2):151-164. PubMed ID: 28597684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: preclinical evidence of immunogenicity and protection.
    Xu DQ; Cisar JO; Osorio M; Wai TT; Kopecko DJ
    Vaccine; 2007 Aug; 25(33):6167-75. PubMed ID: 17629369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and evaluation of live attenuated vaccine strains of Shigella flexneri and Shigella dysenteriae 1.
    Fontaine A; Arondel J; Sansonetti PJ
    Res Microbiol; 1990; 141(7-8):907-12. PubMed ID: 2101481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a new guinea-pig model of shigellosis.
    Barman S; Saha DR; Ramamurthy T; Koley H
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):304-14. PubMed ID: 21539623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shigella infection in macaque colonies: case report of an eradication and control program.
    Wolfensohn S
    Lab Anim Sci; 1998 Aug; 48(4):330-3. PubMed ID: 10090037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiquantitative estimation of Shigella antigen-specific antibodies: correlation with disease severity during shigellosis.
    Islam D; Wretlind B; Hammarström L; Christensson B; Lindberg AA
    APMIS; 1996; 104(7-8):563-74. PubMed ID: 8920810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shigellosis in children: a clinico-epidemiological comparison between Shigella dysenteriae type I and Shigella flexneri.
    Faruque AS; Teka T; Fuchs GJ
    Ann Trop Paediatr; 1998 Sep; 18(3):197-201. PubMed ID: 9924557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shigellosis: the current status of vaccine development.
    Kweon MN
    Curr Opin Infect Dis; 2008 Jun; 21(3):313-8. PubMed ID: 18448978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk areas and neighborhood-level risk factors for Shigella dysenteriae 1 and Shigella flexneri.
    Emch M; Ali M; Yunus M
    Health Place; 2008 Mar; 14(1):96-105. PubMed ID: 17602851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.